Cancer vaccine
MYPI2025003497A0Undetermined Publication Date: 2021-04-18UNIV OF SOUTHAMPTON +1
0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003497
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-10-18
- Filing Date
- 2020-10-19
- Publication Date
- 2021-04-18
Abstract
The present invention relates to nucleic acid vaccines which encode at least a MAGED4B protein, for use in the treatment of cancer in particular. Synergistic combinations with other anti-cancer agents are described, particularly immune checkpoint inhibitors. The cancer vaccine may further comprise an immunologically active fragment to enhance the immune response, and an additional cancer antigen, such as FJX1. Particular combination therapies of interest include immunotherapies, radiotherapy, targeted therapies and chemotherapies. Fig. 1
Need to check novelty before this filing date? Find Prior Art
